We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.58B
AUM Growth
+$568M
Cap. Flow
+$189M
Cap. Flow %
3.39%
Top 10 Hldgs %
17.58%
Holding
1,590
New
158
Increased
732
Reduced
501
Closed
88

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Financials 10.71%
3 Healthcare 10.59%
4 Consumer Discretionary 9.99%
5 Industrials 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITRI icon
1226
Itron
ITRI
$4.32B
$310K 0.01%
3,104
-97
-3% -$9K
SRC
1227
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$310K 0.01%
6,490
+1,684
+35% +$78.9K
EXPE icon
1228
Expedia Group
EXPE
$35.5B
$309K 0.01%
1,891
-131
-6% -$22.5K
NAD icon
1229
Nuveen Quality Municipal Income Fund
NAD
$2.73B
$308K 0.01%
19,266
+1,458
+8% +$22.7K
JMST icon
1230
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.12B
$306K 0.01%
6,000
AES icon
1231
AES
AES
$10.5B
$305K 0.01%
+11,712
New +$309K
LYV icon
1232
Live Nation Entertainment
LYV
$40.7B
$304K 0.01%
3,476
+42
+1% +$3.6K
UTF icon
1233
Cohen & Steers Infrastructure Fund
UTF
$3.1B
$304K 0.01%
10,610
+660
+7% +$19K
CDW icon
1234
CDW
CDW
$18.7B
$302K 0.01%
1,730
-495
-22% -$85.3K
NZF icon
1235
Nuveen Municipal Credit Income Fund
NZF
$2.41B
$302K 0.01%
17,526
+6
+0% +$101
VDC icon
1236
Vanguard Consumer Staples ETF
VDC
$7.98B
$302K 0.01%
1,656
-487
-23% -$89K
ATRA icon
1237
Atara Biotherapeutics
ATRA
$73.1M
$301K 0.01%
774
+23
+3% +$8.2K
ELS icon
1238
Equity Lifestyle Properties
ELS
$12.6B
$301K 0.01%
4,044
-1,944
-32% -$138K
IWV icon
1239
iShares Russell 3000 ETF
IWV
$19.6B
$300K 0.01%
1,174
+2
+0.2% +$499
XMMO icon
1240
Invesco S&P MidCap Momentum ETF
XMMO
$7.13B
$300K 0.01%
3,500
-154
-4% -$12.9K
FPF
1241
First Trust Intermediate Duration Preferred & Income Fund
FPF
$1.08B
$299K 0.01%
11,873
+1,259
+12% +$31.1K
PCN
1242
PIMCO Corporate & Income Strategy Fund
PCN
$871M
$299K 0.01%
15,992
-379
-2% -$6.9K
BHK icon
1243
BlackRock Core Bond Trust
BHK
$646M
$298K 0.01%
18,022
+1,789
+11% +$28.5K
FUN icon
1244
Cedar Fair
FUN
$1.77B
$298K 0.01%
6,647
YORW icon
1245
York Water
YORW
$503M
$298K 0.01%
6,568
-302
-4% -$15K
IWR icon
1246
iShares Russell Mid-Cap ETF
IWR
$56B
$297K 0.01%
3,745
+6
+0.2% +$465
SJM icon
1247
J.M. Smucker
SJM
$12.9B
$297K 0.01%
2,296
+11
+0.5% +$1.46K
UBS icon
1248
UBS Group
UBS
$172B
$297K 0.01%
19,358
+49
+0.3% +$774
WST icon
1249
West Pharmaceutical
WST
$24B
$297K 0.01%
827
+16
+2% +$5.29K
VONV icon
1250
Vanguard Russell 1000 Value ETF
VONV
$20.7B
$296K 0.01%
4,257
-2,909
-41% -$202K

Similar funds

Oppenheimer & Co's Q2 2021 Portfolio in Review

As of Q2 2021, Oppenheimer & Co held 1,590 positions worth $5.58B, up 11% from $5.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $189M of net new capital in Q2 2021, opening 158 new positions and adding to 732 existing holdings. Its largest new stake was Equity Commonwealth: 133,173 shares worth $3.49M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg Convertible Securities ETF, an estimated $8.63M trimmed.

  • Oppenheimer & Co's largest Q2 2021 buy was Equity Commonwealth: 133,173 shares worth $3.49M.
  • Oppenheimer & Co added most to Amazon in Q2 2021, an estimated $10.8M increase.
  • Oppenheimer & Co's biggest Q2 2021 reduction was State Street SPDR Bloomberg Convertible Securities ETF, cutting an estimated $8.63M.
  • Oppenheimer & Co fully exited Armstrong World Industries in Q2 2021, selling an estimated $7.38M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5.58B portfolio in Q2 2021.
  • Oppenheimer & Co opened 158 new positions and closed 88 in Q2 2021.
  • Oppenheimer & Co's portfolio value rose 11% quarter-over-quarter to $5.58B.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.